Bengaluru, NFAPost: SMT (Sahajanand Medical Technology Pvt Ltd), a global medical device company, focusing on innovative patient care in the cardiovascular segment and headquartered in India, today launched the Hydra TAVR device in Central Europe.

Internationally renowned interventional cardiologists Prof. Marek Grygier and Prof. Maciej Lesiak deployed HYDRA successfully at Poland’s Szpital Kliniczny Przemienienia Pańskiego centre.

Transcatheter Aortic Valve Replacement (TAVR) is an established treatment modality for patients who are at high risk or unwilling to undergo open-heart valve replacement surgery. The Hydra aortic valve is a self-expandable nitinol based supra-annular aortic system with a mechanism for recapturing of the valve during deployment. This technology allows for precise placement of the valve and also ensures orthotopic deployment.

Speaking about the successful launch, Marek Kurysz, Country Head of SMT Poland said, “This is a significant step forward for SMT in Central Europe. Structural Heart is really a team effort, thanks to Prof. Grygier and Prof. Lesiak for their trust, Prof. Lars Sondergaard, Dr. Ole DeBacker for their first class proctoring and the TAVI Research Centre (TRC) in Surat for their world class clinical back end support.”

Adding more to the procedure part, Prof. Marek Grygier said,” Hydra aortic valve extends the spectrum of self- expandable valves used in Poland. Based on ESC and Polish Cardiology Society guidelines TAVI operations are performed in patients with heavy stenosis of aortic valve and moderate/increased risk or contraindication to cardiac operation.”

With Hydra valve, SMT strives to achieve greater length of patient care in the structural heart space just like they have done in the coronary interventions sector globally.

Previous articleFlock Launches Various Measures To Keep Employees Engaged While Working From Home
Next articleGoogle Strengthens Quality In Search, Performs Tests On Daily Basis


Please enter your comment!
Please enter your name here